Everolimus Novartis 0,75 mg Tablett

Země: Švédsko

Jazyk: švédština

Zdroj: Läkemedelsverket (Medical Products Agency)

Aktivní složka:

everolimus

Dostupné s:

Novartis Sverige AB

ATC kód:

L04AH02

INN (Mezinárodní Name):

everolimus

Dávkování:

0,75 mg

Léková forma:

Tablett

Složení:

laktos (vattenfri) Hjälpämne; laktosmonohydrat Hjälpämne; butylhydroxitoluen Hjälpämne; everolimus 0,75 mg Aktiv substans

Třída:

Apotek

Druh předpisu:

Receptbelagt

Terapeutické oblasti:

Everolimus

Stav Autorizace:

Avregistrerad

Datum autorizace:

2003-08-08

Informace pro uživatele

1
PACKAGE LEAFLET: INFORMATION FOR THE USER
EVEROLIMUS NOVARTIS 0.25 MG TABLETS
EVEROLIMUS NOVARTIS 0.5 MG TABLETS
EVEROLIMUS NOVARTIS 0.75 MG TABLETS
EVEROLIMUS NOVARTIS 1.0 MG TABLETS
Everolimus
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Everolimus Novartis is and what it is used for
2.
What you need to know before you take Everolimus Novartis
3.
How to take Everolimus Novartis
4.
Possible side effects
5.
How to store Everolimus Novartis
6.
Contents of the pack and other information
1.
WHAT EVEROLIMUS NOVARTIS IS AND WHAT IT IS USED FOR
The active substance of Everolimus Novartis is everolimus.
Everolimus belongs to a group of medicines called immunosuppressants.
It is used in adults to prevent
the body’s immune system from rejecting a transplanted kidney, heart
or liver.
Everolimus Novartis is used together with other medicines, such as
ciclosporin for kidney and heart
transplantation, tacrolimus for liver transplantation, and
corticosteroids.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE EVEROLIMUS NOVARTIS
DO NOT TAKE EVEROLIMUS NOVARTIS

if you are allergic (hypersensitive) to everolimus or any of the other
ingredients of this medicine
(listed in section 6).

if you are allergic (hypersensitive) to sirolimus.
IF ANY OF THE ABOVE APPLIES TO YOU, TELL YOUR DOCTOR AND DO NOT TAKE
EVEROLIMUS NOVARTIS.
WARNINGS AND PRECAUTIONS
TALK TO YOUR DOCTOR BEFORE TAKING EVEROLIMUS NOVARTIS:

Medicines that suppress the immune system like Everolimus Novartis
reduce your body´s
ability

Charakteristika produktu

MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_